Augmentiqs Receives U.S. Patent

Augmentiqs Receives U.S. Patent

After an extensive waiting period, Augmentiqs received official notice of a U.S. patent. The patent is awarded for innovation and usefulness, highlighting the unique method via which Augmentiqs can improve pathology. Gabe Siegel, Augmentiqs CEO and co-founder,...
Collaboration on NIH R01 Grant

Collaboration on NIH R01 Grant

 NIH is Calling for Research into Cancer Image Interpretation, and Augmentiqs is the Most Capable Tool for the Job.Augmentiqs is looking to collaborate with researchers in what is arguably one of the most fascinating and unexplored areas of pathology.NIH (link to...
Discounted Price for 3rd Ocular Cameras

Discounted Price for 3rd Ocular Cameras

 Limited Time Offer – Special Discount on 3rd Ocular Cameras with Augmentiqs Digital Pathology & Telepathology SoftwareAugmentiqs was started with the goal of delivering all the potential of digital pathology within the existing microscope and pathology...
Augmentiqs Telepathology for CDC Covid Response

Augmentiqs Telepathology for CDC Covid Response

Pathologists at CDC Choose Augmentiqs Telepathology for their Covid ResponseThe US Center for Disease and Control (CDC) has chosen Augmentiqs telepathology for their Covid response. By connecting the pathologists’ existing microscope with remote colleagues,...
PRISM Award finalist for Life Science

PRISM Award finalist for Life Science

Augmentiqs was chosen as a finalist in the 2021 Photonics PRISM Award for the prestigious Life Sciences category. Winners to be announced in March.The 2021 Photonics PRISM award finalists have been announced, and Augmentiqs is a finalist in the life sciences...